Home > Compound List > Product Information
Cefazolin_Molecular_structure_CAS_25953-19-9)
Click picture or here to close

Cefazolin

Catalog No. DB01327 Name DrugBank
CAS Number 25953-19-9 Website http://www.ualberta.ca/
M. F. C14H14N8O4S3 Telephone (780) 492-3111
M. W. 454.50716 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1161

SYNONYMS

IUPAC name
(7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[2-(1H-1,2,3,4-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
IUPAC Traditional name
cefazolin
Brand Name
Ancef
Synonyms
CEZ
Cephazolin
Cefazoline
Cefazolin sodium

DATABASE IDS

CAS Number 25953-19-9

PROPERTIES

Hydrophobicity(logP) -0.58 [HANSCH,C ET AL. (1995)]

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. [PubChem]
Indication Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.
Pharmacology Cefazolin (also known as cefazoline or cephazolin) is a semi-synthetic first generation cephalosporin for parenteral administration. Cefazolin has broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Affected Organisms
Enteric bacteria and other eubacteria
Biotransformation Not metabolized.
Absorption Not absorbed from GI tract. Must be administered parenterally. Peak serum concentrations attained 1-2 hours post intramuscular injection.
Half Life The serum half-life is approximately 1.8 hours following IV administration and approximately 2.0 hours following IM administration.
Protein Binding 74-86%
Elimination Cefazolin is present in very low concentrations in the milk of nursing mothers. Cefazolin is excreted unchanged in the urine. In the first six hours approximately 60% of the drug is excreted in the urine and this increases to 70%-80% within 24 hours.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES